Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lilly Contract Sales Team Will Hit The Diabetes Market “Within Weeks”

This article was originally published in The Pink Sheet Daily

Executive Summary

The contract team will also be cross-trained on other Lilly products.

You may also be interested in...

Lilly's Manufacturing Reorg Reflects Changing Diabetes Market Dynamics

Competition from Merck's DPP-4 inhibitor Januvia and progress made by Lilly's own Byetta alter firm's insulin market expectations.

Lilly Will Add 40% Capacity To Diabetes Sales Force In Q1

Firm also announces the submission of an sNDA for Evista for breast cancer risk reduction.

Novo Nordisk To Ramp Up Diabetes Sales Force In 2007

Novo Nordisk tells “The Pink Sheet” DAILY it has started recruiting reps; it intends to add 700 next year.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts